WO2019015156A1 - Screening method for a stabilizer for a chemiluminescent reaction - Google Patents

Screening method for a stabilizer for a chemiluminescent reaction Download PDF

Info

Publication number
WO2019015156A1
WO2019015156A1 PCT/CN2017/107931 CN2017107931W WO2019015156A1 WO 2019015156 A1 WO2019015156 A1 WO 2019015156A1 CN 2017107931 W CN2017107931 W CN 2017107931W WO 2019015156 A1 WO2019015156 A1 WO 2019015156A1
Authority
WO
WIPO (PCT)
Prior art keywords
stabilizer
hydrogen peroxide
concentration
screening
chemiluminescent reagent
Prior art date
Application number
PCT/CN2017/107931
Other languages
French (fr)
Chinese (zh)
Inventor
欧赛英
潘杨斌
周慧琳
Original Assignee
苏州长光华医生物医学工程有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏州长光华医生物医学工程有限公司 filed Critical 苏州长光华医生物医学工程有限公司
Publication of WO2019015156A1 publication Critical patent/WO2019015156A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76Chemiluminescence; Bioluminescence

Definitions

  • the invention relates to a screening method of a chemiluminescence reagent stabilizer, and belongs to the technical field of chemical analysis.
  • Chemiluminescence immunoassay is a novel labeling immunoassay technology that combines a chemiluminescent system with an immune response for the detection of trace antigens or antibodies. It has good selectivity, high sensitivity, strong specificity, no radioactive hazard, and analysis. The advantages of fast speed, simple equipment, etc., have been widely used in the fields of environment, clinical, food, drug testing, etc., and become the research hotspot and development trend of immunoassay methods.
  • acridine compounds As a marker for chemiluminescent immunoassay reagents, acridine compounds have been widely used in chemiluminescence immunoassays. Acridine compounds have many important advantages over other markers (such as radioactive elements, enzymatic labels), such as relatively high sensitivity, low cost, wide linear range, and relatively simple signal detection equipment.
  • acridine compounds have many advantages in the use of chemiluminescence immunoassays, there are still some problems, especially when the chemiluminescence signal is initiated by an oxidation reaction, and some occasional oxidants such as hydrogen peroxide in the liquid reagent.
  • the presence of for example, the surfactant in the reagent will automatically generate hydrogen peroxide, some liquids also have a small amount of hydrogen peroxide, and the reagent will also produce hydrogen peroxide during production, transportation and storage), acridine
  • the marker has a destabilizing effect.
  • components of various stabilizing reagents used in chemiluminescence immunoassay methods such as immunoglobulins, albumin, etc., contain oxidation-sensitive amino acids such as cysteine, methionine, tryptophan, and tyrosine. Etc., can also be oxidized by hydrogen peroxide to eliminate or change biological activity.
  • a change in the activity of the above acridine label or protein results in a decrease in the accuracy of the reagent detection result, and therefore it is necessary to remove some accidental oxidant such as hydrogen peroxide when optimizing the reagent component, but existing
  • the technology has no reference to the choice and dosage of hydrogen peroxide consumption reagents. It is usually necessary to add stabilizers in real time to investigate the real-time stability of the reagents to investigate the hydrogen peroxide consumption capacity of the stabilizers, but this takes up to several months or even one.
  • the technical problem to be solved by the present invention is to provide a screening method for a chemiluminescent reagent stabilizer, which solves the technical problems in the prior art that there is no reference to the selection and dosage of hydrogen peroxide depleting reagents.
  • the chemiluminescence reagent stabilizer detects the hydrogen peroxide consumption ability, and selects a chemiluminescence reagent stabilizer with a suitable hydrogen peroxide consumption capacity according to the detection result, which greatly saves the working intensity and time for screening the chemiluminescence reagent stabilizer.
  • a screening method for a chemiluminescent reagent stabilizer comprising the following steps,
  • the excitation liquid collects the total number of photons in a period of time, and obtains a standard curve by the correspondence between the total photon number and the concentration of the hydrogen peroxide standard solution;
  • the number of parts is at least 1 part more than the stabilizer, and add to one of the hydrogen peroxide standard solutions.
  • the high-purity water with the same volume of high-purity water in the process of establishing the standard curve, and the other hydrogen peroxide standard solution are added with the same volume of the high-purity water in the process of establishing the standard curve, respectively, and then separately added to the volume.
  • a chemiluminescent reagent stabilizer having a suitable hydrogen peroxide consumption ability is selected according to the hydrogen peroxide degradation rate of each stabilizer.
  • the chemiluminescence detecting reagent is an acridine sulfonamide solution, and the structural formula of the acridine sulfonamide is as follows:
  • R and R' are one selected from the group consisting of an alkyl group and a substituent thereof, and X and X' are one selected from the group consisting of a sulfonyl group, a halogen, a carboxyl group, and an N-hydroxysuccinimide.
  • the acridine sulfonamide is one of the following structures:
  • the stabilizer is one or more of BSA, a reducing amino acid, and a reducing buffer.
  • the stabilizer is BSA, glycine, glutamic acid, lysine, histidine, PB, citric acid-Na 2 HPO 4 , citric acid-TRIS, MES-TRIS, MES-NaOH buffer One or several.
  • the buffer is acidic.
  • the incubation temperature is 37 ° C and the time is from 0.5 h to 240 h.
  • said D is at least 5 seconds.
  • (1) Screening method of the chemiluminescent reagent stabilizer of the present invention First, several kinds of chemiluminescent reagent stabilizers are selected, and the consumption ability of each chemiluminescent reagent stabilizer for hydrogen peroxide is detected, and hydrogen peroxide is selected according to the detection result. A chemiluminescent reagent stabilizer that is suitable for consumption. The method greatly saves the working intensity and time of the screening reagent stabilizer, and the detection is fast and efficient, and provides a reference for the selection and dosage of the chemiluminescent reagent stabilizer.
  • the acridine sulfonamide of the present invention is suitable for determining the hydrogen peroxide content of different pH solutions after the addition of the stabilizer, and the measurement result is accurate.
  • the present embodiment provides a screening method for a chemiluminescent reagent stabilizer, which comprises the steps of selecting amino acids such as glycine, lysine, histidine and glutamic acid as stabilizers for chemiluminescent reagents, and peroxidizing each amino acid.
  • the degradation rate of hydrogen is detected, and according to the detection result, an amino acid having a suitable hydrogen peroxide consumption capacity can be selected, and the steps of detecting the hydrogen peroxide consumption ability of the different amino acids are as follows:
  • amino acids with suitable hydrogen peroxide consumption capacity can be selected.
  • glycine, lysine and histidine can be selected as stabilizers, when peroxide consumption capacity is required.
  • glutamic acid can be selected as a stabilizer.
  • the detection is performed, and according to the detection result, a buffer having a suitable hydrogen peroxide consumption capacity can be selected, and the detection steps of the different buffers for the hydrogen peroxide consumption ability are as follows:
  • acridinesulfonamide itself is unstable in an alkaline environment, it is slow to select a luminescent reagent.
  • the flushing is all acidic. It can be seen from the above table that the buffers of PB and MES-NaOH in the buffer selected from the experiment cannot consume hydrogen peroxide, and the citric acid-Na2HPO4 and citric acid-TRIS show strong hydrogen peroxide consumption capacity, while MES -TRIS has a relatively weak ability to degrade hydrogen peroxide. Actually, a buffer suitable for hydrogen peroxide consumption can be selected according to the detection result.
  • citric acid-Na2HPO4 and citric acid-TRIS can be selected as stabilizers, and when peroxide consumption is required.
  • MES-TRIS can be selected as a stabilizer.
  • this example uses BSA as a stabilizer to select different concentrations of BSA to detect the hydrogen peroxide consumption capacity. According to the test results, hydrogen peroxide consumption capacity can be selected.
  • a suitable concentration of stabilizer, the steps of detecting the hydrogen peroxide consumption capacity of the different concentrations of BSA are as follows:
  • BSA is a globulin in bovine serum. Since it has a reducing cysteine residue on the surface and is reducible, it can consume hydrogen peroxide in the solution to protect the stability of the luminescent reagent. As can be seen from the above table, it can be seen from the results that the higher the BSA concentration, the higher the degradation rate of hydrogen peroxide under the same incubation time. Actually, a stabilizer suitable for the consumption of hydrogen peroxide can be selected according to the test result. For example, when the peroxide consumption capacity is required, a higher concentration of the stabilizer can be selected, and when the peroxide consumption capacity is required to be weak, choose a lower concentration of stabilizer.
  • this example uses BSA as a stabilizer to select 1% BSA to detect the consumption capacity of 2.5 ⁇ M-250 ⁇ M hydrogen peroxide.
  • concentration of hydrogen peroxide is selected to be a certain concentration and kind of stabilizer having a suitable hydrogen peroxide consumption capacity.
  • the procedure for detecting the consumption capacity of the 1% BSA for 2.5 ⁇ M-250 ⁇ M hydrogen peroxide is as follows:
  • the consumption of hydrogen peroxide by BSA is a gradual process.
  • concentration of hydrogen peroxide the slower the degradation rate of hydrogen peroxide by the stabilizer BSA.
  • a stabilizer suitable for hydrogen peroxide consumption can be selected according to the detection result. For example, when the hydrogen peroxide content in the chemiluminescence reagent is high, a stabilizer having a relatively high concentration of peroxide consumption can be selected, when chemiluminescence is obtained. When the hydrogen peroxide content of the reagent is low, a stabilizer having a relatively low concentration of peroxide consumption can be selected.
  • the invention adopts a kind of structure of acridine sulfonamide, and the quantitative analysis method of hydrogen peroxide is used to determine the consumption capacity of the stabilizer for hydrogen peroxide.
  • the pH of the solution changes due to the addition of a stabilizer and no stabilizer, and the standard
  • the curve is made without a stabilizer, and the acridine sulfonamide used in the present invention is suitable for determining the hydrogen peroxide content of different pH solutions after the addition of the stabilizer.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Plasma & Fusion (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

A screening method for a stabilizer in a chemiluminescent reaction. The method uses a first structure type acridine sulfonamide to conduct hydrogen peroxide testing in order to observe the ability of different stabilizers to consume hydrogen peroxide. The stabilizers comprise the following substances with reducing properties: BSA, reduced amino acids such as glycine, lycine and histidine, citric acid, and TRIS buffers. The method is used to provide a reference for the selection and usage of a stabilizer in a chemiluminescent reaction.

Description

一种化学发光试剂稳定剂的筛选方法Method for screening chemiluminescence reagent stabilizer 技术领域Technical field
本发明涉及一种化学发光试剂稳定剂的筛选方法,属于化学分析技术领域。The invention relates to a screening method of a chemiluminescence reagent stabilizer, and belongs to the technical field of chemical analysis.
背景技术Background technique
化学发光发光免疫分析是将化学发光体系与免疫反应相结合,用于检测微量抗原或抗体的一种新型标记免疫测定技术,它具有选择性好、灵敏度高、特异性强、无放射性危害、分析速度快、设备简单等优点,在环境、临床、食品、药物检测等领域得到了广泛应用,成为免疫分析方法的研究热点和发展趋势。Chemiluminescence immunoassay is a novel labeling immunoassay technology that combines a chemiluminescent system with an immune response for the detection of trace antigens or antibodies. It has good selectivity, high sensitivity, strong specificity, no radioactive hazard, and analysis. The advantages of fast speed, simple equipment, etc., have been widely used in the fields of environment, clinical, food, drug testing, etc., and become the research hotspot and development trend of immunoassay methods.
吖啶化合物作为一种化学发光免疫分析试剂的标记物,在化学发光发光免疫分析中得到了广泛的应用。吖啶化合物跟其他标记物(如放射元素标记、酶标记)相比,有许多重要优势,比如相对高的灵敏度,低成本、线性范围宽,相对简单的信号检测设备等。As a marker for chemiluminescent immunoassay reagents, acridine compounds have been widely used in chemiluminescence immunoassays. Acridine compounds have many important advantages over other markers (such as radioactive elements, enzymatic labels), such as relatively high sensitivity, low cost, wide linear range, and relatively simple signal detection equipment.
尽管吖啶化合物在化学发光免疫分析的使用中有诸多优势,但仍存在一些问题,尤其是此化学发光信号启动是由一个氧化反应启动的,而液体试剂中一些偶然的氧化剂如过氧化氢等的存在(例如试剂中的表面活性剂会自动生成过氧化氢,一些液体里本身也有少量的过氧化氢,另外试剂在生产、运输、储存的过程中也会产生过氧化氢),对吖啶标记物有一个去稳定的作用。另外,化学发光免疫分析方法中使用的各种稳定试剂的组分,如免疫球蛋白、白蛋白等,含有氧化敏感的氨基酸如半胱氨酸、甲硫氨酸、色氨酸、酪氨酸等,也能被过氧化氢氧化从而生物活性消失或改变。Although acridine compounds have many advantages in the use of chemiluminescence immunoassays, there are still some problems, especially when the chemiluminescence signal is initiated by an oxidation reaction, and some occasional oxidants such as hydrogen peroxide in the liquid reagent. The presence of (for example, the surfactant in the reagent will automatically generate hydrogen peroxide, some liquids also have a small amount of hydrogen peroxide, and the reagent will also produce hydrogen peroxide during production, transportation and storage), acridine The marker has a destabilizing effect. In addition, components of various stabilizing reagents used in chemiluminescence immunoassay methods, such as immunoglobulins, albumin, etc., contain oxidation-sensitive amino acids such as cysteine, methionine, tryptophan, and tyrosine. Etc., can also be oxidized by hydrogen peroxide to eliminate or change biological activity.
上述吖啶标记物或蛋白质活性的改变会导致试剂检测结果的准确性降低,因此,在优化试剂组分时有必要去除一些偶然的氧化剂如过氧化氢,但是现有 技术在过氧化氢消耗试剂的选择和用量上尚没有参考依据,通常需要实时添加稳定剂以考察试剂的实时稳定性来考察稳定剂的过氧化氢消耗能力,但这需要长达数月甚至一到两年时间,因此需要建立一种快速测量方法来考察稳定剂的过氧化氢消耗能力,预先筛选出过氧化氢消耗能力合适的化学发光试剂稳定剂,为试剂稳定性研究提供指导依据。A change in the activity of the above acridine label or protein results in a decrease in the accuracy of the reagent detection result, and therefore it is necessary to remove some accidental oxidant such as hydrogen peroxide when optimizing the reagent component, but existing The technology has no reference to the choice and dosage of hydrogen peroxide consumption reagents. It is usually necessary to add stabilizers in real time to investigate the real-time stability of the reagents to investigate the hydrogen peroxide consumption capacity of the stabilizers, but this takes up to several months or even one. In two years, it is necessary to establish a rapid measurement method to investigate the hydrogen peroxide consumption capacity of the stabilizer, and pre-screen the chemiluminescence reagent stabilizer with suitable hydrogen peroxide consumption ability, which provides a guiding basis for the stability study of the reagent.
发明内容Summary of the invention
本发明要解决的技术问题是:为解决现有技术在过氧化氢消耗试剂的选择和用量上无参考依据的技术问题,提供一种化学发光试剂稳定剂的筛选方法,该方法通过对各种化学发光试剂稳定剂对过氧化氢的消耗能力进行检测,根据检测结果选择过氧化氢消耗能力合适的化学发光试剂稳定剂,极大地节省了筛选化学发光试剂稳定剂的工作强度和时间。The technical problem to be solved by the present invention is to provide a screening method for a chemiluminescent reagent stabilizer, which solves the technical problems in the prior art that there is no reference to the selection and dosage of hydrogen peroxide depleting reagents. The chemiluminescence reagent stabilizer detects the hydrogen peroxide consumption ability, and selects a chemiluminescence reagent stabilizer with a suitable hydrogen peroxide consumption capacity according to the detection result, which greatly saves the working intensity and time for screening the chemiluminescence reagent stabilizer.
本发明为解决其技术问题所采用的技术方案是:The technical solution adopted by the present invention to solve the technical problem thereof is:
一种化学发光试剂稳定剂的筛选方法,包括以下步骤,A screening method for a chemiluminescent reagent stabilizer, comprising the following steps,
选定若干种稳定剂;Selected several stabilizers;
取体积为V1的一系列的C0-C1浓度范围的过氧化氢标准溶液,分别向其中加入高纯水和体积为V2、浓度为C2的化学发光检测试剂,并立即加入体积为V3、浓度为C3的激发液,分别收集一段时间内的总光子数,通过总光子数与过氧化氢标准溶液的浓度之间的对应关系得到标准曲线;Take a series of C0-C1 concentration range of hydrogen peroxide standard solution with a volume of V1, and add high-purity water and a chemiluminescence detection reagent with a volume of V2 and a concentration of C2, respectively, and immediately add a volume of V3 and a concentration of C3. The excitation liquid collects the total number of photons in a period of time, and obtains a standard curve by the correspondence between the total photon number and the concentration of the hydrogen peroxide standard solution;
取与建立标准曲线时相同体积的C0-C1浓度范围内某一浓度的过氧化氢标准溶液若干份,份数至少为比稳定剂数量多1份,向其中一份过氧化氢标准溶液中加入与建立标准曲线过程中高纯水体积相同的高纯水,其余份过氧化氢标准溶液中加入与建立标准曲线过程中高纯水体积相同的某一种稳定剂,分别进行温育后,再分别加入体积为V2、浓度为C2的化学发光检测试剂,并立即加入 与体积为V3、浓度为C3的激发液,分别收集与建立标准曲线过程中相同时间内的总光子数;将加入某一种稳定剂和高纯水后所测总光子数与建立的标准曲线进行比照,分别得到加入每一种稳定剂后的过氧化氢浓度C'和未加稳定剂的过氧化氢浓度C,根据公式降解率(H2O2)=(C-C')/C*100%,计算得到每一种稳定剂的过氧化氢降解率;Take a certain concentration of hydrogen peroxide standard solution in the same volume of C0-C1 concentration range as the standard curve, the number of parts is at least 1 part more than the stabilizer, and add to one of the hydrogen peroxide standard solutions. The high-purity water with the same volume of high-purity water in the process of establishing the standard curve, and the other hydrogen peroxide standard solution are added with the same volume of the high-purity water in the process of establishing the standard curve, respectively, and then separately added to the volume. V2, a chemiluminescence detection reagent with a concentration of C2, and immediately added Collecting the total number of photons in the same period of time as the standard curve is established with the excitation liquid with volume V3 and concentration C3; comparing the total photon number measured after adding a certain stabilizer and high purity water with the established standard curve , respectively, the hydrogen peroxide concentration C' after adding each stabilizer and the hydrogen peroxide concentration C without the stabilizer are obtained, and the calculation rate is calculated according to the formula degradation rate (H2O2)=(CC')/C*100%. a hydrogen peroxide degradation rate of a stabilizer;
根据每种稳定剂的过氧化氢降解率选择过氧化氢消耗能力合适的化学发光试剂稳定剂。A chemiluminescent reagent stabilizer having a suitable hydrogen peroxide consumption ability is selected according to the hydrogen peroxide degradation rate of each stabilizer.
优选地,V2·C2≥1.5(V1·C1),且V2·C2=(2-5)V3·C3。Preferably, V2 · C2 ≥ 1.5 (V1 · C1), and V2 · C2 = (2-5) V3 · C3.
优选地,所述化学发光检测试剂为吖啶磺酰胺溶液,所述吖啶磺酰胺的结构式中如下:Preferably, the chemiluminescence detecting reagent is an acridine sulfonamide solution, and the structural formula of the acridine sulfonamide is as follows:
Figure PCTCN2017107931-appb-000001
Figure PCTCN2017107931-appb-000001
其中,R、R'选自烷基及其取代物中的一种,X、X'选自磺酰基、卤素、羧基、N-羟基琥珀酰亚胺中的一种。Wherein R and R' are one selected from the group consisting of an alkyl group and a substituent thereof, and X and X' are one selected from the group consisting of a sulfonyl group, a halogen, a carboxyl group, and an N-hydroxysuccinimide.
优选地,所述吖啶磺酰胺为下述结构中的一种:Preferably, the acridine sulfonamide is one of the following structures:
Figure PCTCN2017107931-appb-000002
Figure PCTCN2017107931-appb-000002
Figure PCTCN2017107931-appb-000003
Figure PCTCN2017107931-appb-000003
优选地,所述稳定剂为BSA、还原性氨基酸和还原性缓冲液中的一种或几种。Preferably, the stabilizer is one or more of BSA, a reducing amino acid, and a reducing buffer.
优选地,所述稳定剂为BSA、甘氨酸、谷氨酸、赖氨酸、组氨酸、PB、柠檬酸-Na2HPO4、柠檬酸-TRIS、MES-TRIS、MES-NaOH缓冲液中的一种或几种。Preferably, the stabilizer is BSA, glycine, glutamic acid, lysine, histidine, PB, citric acid-Na 2 HPO 4 , citric acid-TRIS, MES-TRIS, MES-NaOH buffer One or several.
优选地,所述缓冲液为酸性。Preferably, the buffer is acidic.
优选地,所述温育温度为37℃,时间为0.5h-240h。Preferably, the incubation temperature is 37 ° C and the time is from 0.5 h to 240 h.
优选地,所述D至少为5秒。Preferably, said D is at least 5 seconds.
本发明的有益效果是:The beneficial effects of the invention are:
(1)本发明的化学发光试剂稳定剂的筛选方法首先选定若干种化学发光试剂稳定剂,对每个化学发光试剂稳定剂对过氧化氢的消耗能力进行检测,根据检测结果选择过氧化氢消耗能力合适的化学发光试剂稳定剂。该方法极大地节省了筛选试剂稳定剂的工作强度和时间,检测快速高效,给化学发光试剂稳定剂的选择和用量上提供了参考依据。(1) Screening method of the chemiluminescent reagent stabilizer of the present invention First, several kinds of chemiluminescent reagent stabilizers are selected, and the consumption ability of each chemiluminescent reagent stabilizer for hydrogen peroxide is detected, and hydrogen peroxide is selected according to the detection result. A chemiluminescent reagent stabilizer that is suitable for consumption. The method greatly saves the working intensity and time of the screening reagent stabilizer, and the detection is fast and efficient, and provides a reference for the selection and dosage of the chemiluminescent reagent stabilizer.
(2)本发明的化学发光试剂稳定剂的筛选方法在测定过氧化氢的消耗率时,由于加稳定剂和不加稳定剂,溶液的pH有所变化,而标准曲线是在不加稳定剂时做出的,本发明采用一类结构的吖啶磺酰胺适用于测定加稳定剂后的不同pH溶液的过氧化氢含量,测定结果准确。(2) Screening method of the chemiluminescent reagent stabilizer of the present invention When measuring the consumption rate of hydrogen peroxide, the pH of the solution changes due to the addition of a stabilizer and no stabilizer, and the standard curve is without a stabilizer. In the present invention, the acridine sulfonamide of the present invention is suitable for determining the hydrogen peroxide content of different pH solutions after the addition of the stabilizer, and the measurement result is accurate.
具体实施方式Detailed ways
实施例1 Example 1
本实施例提供一种化学发光试剂稳定剂的筛选方法,包括以下步骤,选定甘氨酸、赖氨酸、组氨酸和谷氨酸等氨基酸作为化学发光试剂稳定剂,对每个氨基酸对过氧化氢的降解率进行检测,根据检测结果可以选择过氧化氢消耗能力合适的氨基酸,所述不同氨基酸对过氧化氢消耗能力的检测步骤如下:The present embodiment provides a screening method for a chemiluminescent reagent stabilizer, which comprises the steps of selecting amino acids such as glycine, lysine, histidine and glutamic acid as stabilizers for chemiluminescent reagents, and peroxidizing each amino acid. The degradation rate of hydrogen is detected, and according to the detection result, an amino acid having a suitable hydrogen peroxide consumption capacity can be selected, and the steps of detecting the hydrogen peroxide consumption ability of the different amino acids are as follows:
取50μL浓度为2.5μM、10μM、40μM、100μM、250μM的过氧化氢标准溶液,向其中加入体积为50μL高纯水和50μL浓度为2M的吖啶磺酰胺溶液,并立即加入100μL浓度为0.25M的氢氧化钠溶液,分别收集5S的总光子数,通过总光子数与过氧化氢标准溶液的浓度之间的对应关系得到线性标准曲线,y=10658x+5963.1,R2=0.9998;Take 50 μL of 2.5 μM, 10 μM, 40 μM, 100 μM, 250 μM hydrogen peroxide standard solution, add 50 μL of high purity water and 50 μL of 2 M acridine sulfonamide solution, and immediately add 100 μL of hydrogen at a concentration of 0.25 M. The sodium oxide solution was used to collect the total photon number of 5S, and the linear standard curve was obtained by the correspondence between the total photon number and the concentration of the hydrogen peroxide standard solution, y=10658x+5963.1, R 2 =0.9998;
取50μL浓度为10μM的过氧化氢标准溶液两份,向其中一份加入50μL浓度为1%的氨基酸,另一份加入50μL高纯水作为对照,分别于37℃下温育0.5h、12h、24h、72h、240h后,加入50μL浓度为2M的吖啶磺酰胺溶液,并立即加入100μL浓度为0.25M的氢氧化钠溶液,分别收集5S后的总光子数;Take 50 μL of a 10 μM hydrogen peroxide standard solution, add 50 μL of 1% amino acid to one part, and add 50 μL of high purity water as a control, and incubate at 37 ° C for 0.5 h, 12 h, 24 h, respectively. After 72h and 240h, 50 μL of 2M acridinesulfonamide solution was added, and 100 μL of 0.25 M sodium hydroxide solution was added immediately, and the total photon number after 5S was collected.
将检测步骤中所测总光子数与建立的线性标准曲线进行对照,通过计算得到加入稳定剂后的过氧化氢浓度C'和未加稳定剂的过氧化氢浓度C,根据公式降解率(H2O2)=(C-C')/C*100%,计算得到过氧化氢的降解率。Comparing the total number of photons measured in the detection step with the established linear standard curve, and calculating the hydrogen peroxide concentration C' after adding the stabilizer and the hydrogen peroxide concentration C without the stabilizer, according to the formula degradation rate (H) 2 O 2 )=(CC')/C*100%, and the degradation rate of hydrogen peroxide was calculated.
所述吖啶磺酰胺的结构式中如下:The structural formula of the acridine sulfonamide is as follows:
Figure PCTCN2017107931-appb-000004
Figure PCTCN2017107931-appb-000004
各种氨基酸在不同温育时间下的降解率结果如下表: The degradation rates of various amino acids at different incubation times are shown in the following table:
Figure PCTCN2017107931-appb-000005
Figure PCTCN2017107931-appb-000005
由上表可以看出,实验选取的氨基酸稳定剂都具备一定的过氧化氢消耗能力,其中,甘氨酸、赖氨酸和组氨酸均显示较强的过氧化氢消耗能力,而谷氨酸对过氧化氢的降解能力较弱。实际可根据检测结果选择过氧化氢消耗能力合适的氨基酸,比如,当需要过氧化物消耗能力较强时,可以选择甘氨酸、赖氨酸和组氨酸作为稳定剂,当需要过氧化物消耗能力较弱时,可以选择谷氨酸作为稳定剂。It can be seen from the above table that the amino acid stabilizers selected in the experiment all have certain hydrogen peroxide consumption ability, among which glycine, lysine and histidine all show strong hydrogen peroxide consumption ability, while glutamic acid pair The degradation ability of hydrogen peroxide is weak. Actually, according to the test results, amino acids with suitable hydrogen peroxide consumption capacity can be selected. For example, when the peroxide consumption capacity is strong, glycine, lysine and histidine can be selected as stabilizers, when peroxide consumption capacity is required. When it is weak, glutamic acid can be selected as a stabilizer.
实施例2Example 2
本实施例提供一种化学发光试剂稳定剂的筛选方法,包括以下步骤,选定0.1M PB(pH=6.8)、0.1M柠檬酸-Na2HPO4(pH=6.8)、0.1M柠檬酸-TRIS(pH=6.8)、0.1M MES-TRIS(pH=6.8)、0.1M MES-NaOH(pH=6.8)等缓冲液作为化学发光试剂稳定剂,对每种缓冲液对过氧化氢的消耗能力进行检测,根据检测结果可以选择过氧化氢消耗能力合适的缓冲液,所述不同缓冲液对过氧化氢消耗能力的检测步骤如下:This embodiment provides a screening method for a chemiluminescent reagent stabilizer, comprising the following steps: selecting 0.1 M PB (pH=6.8), 0.1 M citric acid-Na 2 HPO 4 (pH=6.8), 0.1 M citric acid- Buffers such as TRIS (pH=6.8), 0.1M MES-TRIS (pH=6.8), 0.1M MES-NaOH (pH=6.8) as chemiluminescent reagent stabilizers, the ability to consume hydrogen peroxide for each buffer The detection is performed, and according to the detection result, a buffer having a suitable hydrogen peroxide consumption capacity can be selected, and the detection steps of the different buffers for the hydrogen peroxide consumption ability are as follows:
取100μL浓度为2.5μM、10μM、40μM、100μM、250μM的过氧化氢标准溶液,向其中加入体积为150μL高纯水和150μL浓度为1M的吖啶磺酰胺溶液,并立即加入50μL浓度为0.6M的氢氧化钠溶液,分别收集5S的总光子数, 通过总光子数与过氧化氢标准溶液的浓度之间的对应关系得到线性标准曲线,y=15628x+4543.2,R2=0.9999;100 μL of a 2.5 μM, 10 μM, 40 μM, 100 μM, 250 μM hydrogen peroxide standard solution was added thereto, and 150 μL of high-purity water and 150 μL of a 1 M acridine sulfonamide solution were added thereto, and 50 μL of hydrogen having a concentration of 0.6 M was immediately added. The sodium oxide solution was used to collect the total photon number of 5S, and the linear standard curve was obtained by the correspondence between the total photon number and the concentration of the hydrogen peroxide standard solution, y=15628x+4543.2, R 2 =0.9999;
取100μL浓度为10μM的过氧化氢标准溶液两份,向其中一份加入150μL浓度为0.1M的缓冲液,另一份加入150μL高纯水作为对照,分别于37℃下温育0.5h、12h、24h、72h、240h后,加入150μL浓度为1M的吖啶磺酰胺溶液,并立即加入50μL浓度为0.6M的氢氧化钠溶液,分别收集5S后的总光子数;Take 100 μL of 10 μM hydrogen peroxide standard solution, add 150 μL of 0.1 M buffer to one part, and add 150 μL of high purity water as control. Incubate at 37 ° C for 0.5 h, 12 h, 24 h. After 72h and 240h, 150 μL of a 1 M acridine sulfonamide solution was added, and 50 μL of a 0.6 M sodium hydroxide solution was immediately added to collect the total photon number after 5 S;
将检测步骤中所测总光子数与建立的线性标准曲线进行对照,通过计算得到加入稳定剂后的过氧化氢浓度C'和未加稳定剂的过氧化氢浓度C,根据公式降解率(H2O2)=(C-C')/C*100%,计算得到过氧化氢的降解率。Comparing the total number of photons measured in the detection step with the established linear standard curve, and calculating the hydrogen peroxide concentration C' after adding the stabilizer and the hydrogen peroxide concentration C without the stabilizer, according to the formula degradation rate (H) 2 O 2 )=(CC')/C*100%, and the degradation rate of hydrogen peroxide was calculated.
所述吖啶磺酰胺的结构式中如下:The structural formula of the acridine sulfonamide is as follows:
Figure PCTCN2017107931-appb-000006
Figure PCTCN2017107931-appb-000006
各种缓冲液在不同温育时间下的降解率结果如下表:The degradation rates of various buffers at different incubation times are shown in the following table:
Figure PCTCN2017107931-appb-000007
Figure PCTCN2017107931-appb-000007
由于吖啶磺酰胺本身在碱性环境下不稳定,所以选取能稳定发光试剂的缓 冲液都偏酸性。由上表可以看出,实验选取的缓冲液中PB和MES-NaOH两种缓冲液不能消耗过氧化氢,柠檬酸-Na2HPO4、柠檬酸-TRIS显示出较强的过氧化氢消耗能力,而MES-TRIS对过氧化氢的降解能力相对较弱。实际可根据检测结果选择过氧化氢消耗能力合适的缓冲液,比如,当需要过氧化物消耗能力较强时,可以选择柠檬酸-Na2HPO4、柠檬酸-TRIS作为稳定剂,当需要过氧化物消耗能力较弱时,可以选择MES-TRIS作为稳定剂。Since acridinesulfonamide itself is unstable in an alkaline environment, it is slow to select a luminescent reagent. The flushing is all acidic. It can be seen from the above table that the buffers of PB and MES-NaOH in the buffer selected from the experiment cannot consume hydrogen peroxide, and the citric acid-Na2HPO4 and citric acid-TRIS show strong hydrogen peroxide consumption capacity, while MES -TRIS has a relatively weak ability to degrade hydrogen peroxide. Actually, a buffer suitable for hydrogen peroxide consumption can be selected according to the detection result. For example, when a peroxide consumption capacity is required, citric acid-Na2HPO4 and citric acid-TRIS can be selected as stabilizers, and when peroxide consumption is required. When the ability is weak, MES-TRIS can be selected as a stabilizer.
实施例3Example 3
为考察不同浓度稳定剂对过氧化氢的消耗能力,本实施例以BSA作为稳定剂为例,选定不同浓度BSA对过氧化氢的消耗能力进行检测,根据检测结果可以选择过氧化氢消耗能力合适的一定浓度的稳定剂,所述不同浓度BSA对过氧化氢消耗能力的检测步骤如下:In order to investigate the ability of different concentrations of stabilizers to consume hydrogen peroxide, this example uses BSA as a stabilizer to select different concentrations of BSA to detect the hydrogen peroxide consumption capacity. According to the test results, hydrogen peroxide consumption capacity can be selected. A suitable concentration of stabilizer, the steps of detecting the hydrogen peroxide consumption capacity of the different concentrations of BSA are as follows:
取150μL浓度为2.5μM、10μM、40μM、100μM、250μM的过氧化氢标准溶液,向其中加入体积为100μL高纯水和100μL浓度为0.5625M的吖啶磺酰胺溶液,并立即加入150μL浓度为0.1875M的氢氧化钠溶液,分别收集5S的总光子数,通过总光子数与过氧化氢标准溶液的浓度之间的对应关系得到线性标准曲线,y=6758x+6356.5,R2=0.9998;150 μL of a 2.5 μM, 10 μM, 40 μM, 100 μM, 250 μM hydrogen peroxide standard solution was added thereto, and a volume of 100 μL of high-purity water and 100 μL of a 0.5625 M acridine sulfonamide solution were added thereto, and 150 μL of a concentration of 0.1875 M was immediately added. The sodium hydroxide solution was used to collect the total photon number of 5S, and the linear standard curve was obtained by the correspondence between the total photon number and the concentration of the hydrogen peroxide standard solution, y=6758x+6356.5, R 2 =0.9998;
取150μL浓度为40μM的过氧化氢标准溶液两份,向其中一份加入100μL0.1%-10%浓度范围的BSA,另一份加入100μL高纯水作为对照,分别于37℃下温育0.5h、12h、24h、72h、240h后,加入100μL浓度为0.5625M的吖啶磺酰胺溶液,并立即加入150μL浓度为0.1875M的氢氧化钠溶液,分别收集5S后的总光子数;Take 150 μL of a 40 μM hydrogen peroxide standard solution, add 100 μL of BSA in the range of 0.1%-10% to one part, and add 100 μL of high-purity water as a control in the other, and incubate at 37 ° C for 0.5 h. After 12h, 24h, 72h, 240h, 100 μL of 0.5625 M acridine sulfonamide solution was added, and 150 μL of 0.1875 M sodium hydroxide solution was immediately added to collect the total photon number after 5S;
将检测步骤中所测总光子数与建立的线性标准曲线进行对照,通过计算得 到加入稳定剂后的过氧化氢浓度C'和未加稳定剂的过氧化氢浓度C,根据公式降解率(H2O2)=(C-C')/C*100%,计算得到过氧化氢的降解率。Comparing the total number of photons measured in the detection step with the established linear standard curve, and calculating the hydrogen peroxide concentration C' after adding the stabilizer and the hydrogen peroxide concentration C without the stabilizer, according to the formula degradation rate (H) 2 O 2 )=(CC')/C*100%, and the degradation rate of hydrogen peroxide was calculated.
所述吖啶磺酰胺的结构式中如下:The structural formula of the acridine sulfonamide is as follows:
Figure PCTCN2017107931-appb-000008
Figure PCTCN2017107931-appb-000008
不同浓度的BSA在不同温育时间下的降解率结果如下表:The degradation rates of different concentrations of BSA under different incubation times are shown in the following table:
Figure PCTCN2017107931-appb-000009
Figure PCTCN2017107931-appb-000009
BSA是牛血清中的球蛋白,因为表面含有还原性的半胱氨酸残基而具有还原性,所以能消耗溶液中的过氧化氢而保护发光试剂的稳定性。由上表可以看出,从结果可见,相同温育时间下,BSA浓度越高,对过氧化氢的降解率越高。实际可根据检测结果选择过氧化氢消耗能力合适的稳定剂,比如,当需要过氧化物消耗能力较强时,可以选择较高浓度的稳定剂,当需要过氧化物消耗能力较弱时,可以选择较低浓度的稳定剂。BSA is a globulin in bovine serum. Since it has a reducing cysteine residue on the surface and is reducible, it can consume hydrogen peroxide in the solution to protect the stability of the luminescent reagent. As can be seen from the above table, it can be seen from the results that the higher the BSA concentration, the higher the degradation rate of hydrogen peroxide under the same incubation time. Actually, a stabilizer suitable for the consumption of hydrogen peroxide can be selected according to the test result. For example, when the peroxide consumption capacity is required, a higher concentration of the stabilizer can be selected, and when the peroxide consumption capacity is required to be weak, Choose a lower concentration of stabilizer.
实施例4 Example 4
为考察稳定剂对不同浓度过氧化氢的消耗能力,本实施例以BSA作为稳定剂为例,选定1%BSA对2.5μM-250μM过氧化氢的消耗能力进行检测,根据检测结果可根据过氧化氢的浓度选择过氧化氢消耗能力合适的一定浓度和种类的稳定剂,所述1%BSA对2.5μM-250μM过氧化氢的消耗能力的检测步骤如下:In order to investigate the ability of stabilizers to consume hydrogen peroxide at different concentrations, this example uses BSA as a stabilizer to select 1% BSA to detect the consumption capacity of 2.5μM-250μM hydrogen peroxide. The concentration of hydrogen peroxide is selected to be a certain concentration and kind of stabilizer having a suitable hydrogen peroxide consumption capacity. The procedure for detecting the consumption capacity of the 1% BSA for 2.5 μM-250 μM hydrogen peroxide is as follows:
取50μL浓度为2.5μM、10μM、40μM、100μM、250μM的过氧化氢标准溶液,向其中加入体积为50μL高纯水和50μL浓度为2M的吖啶磺酰胺溶液,并立即加入100μL浓度为0.35M的氢氧化钠溶液,分别收集5S的总光子数,通过总光子数与过氧化氢标准溶液的浓度之间的对应关系得到线性标准曲线,y=11028x+5375.4,R2=0.9998;Take 50 μL of 2.5 μM, 10 μM, 40 μM, 100 μM, 250 μM hydrogen peroxide standard solution, add 50 μL of high purity water and 50 μL of 2 M acridine sulfonamide solution, and immediately add 100 μL of hydrogen at a concentration of 0.35 M. The sodium oxide solution was used to collect the total photon number of 5S, and the linear standard curve was obtained by the correspondence between the total photon number and the concentration of the hydrogen peroxide standard solution, y=11028x+5375.4, R 2 =0.9998;
取50μL浓度为2.5μM、10μM、40μM、100μM、250μM过氧化氢标准溶液各两份,向相同浓度的其中一份过氧化氢标准溶液加入50μL浓度为1%的BSA,另一份加入50μL高纯水作为对照,分别于37℃下温育0.5h、12h、24h、72h、240h后,加入50μL浓度为2M的吖啶磺酰胺溶液,并立即加入100μL浓度为0.25M的氢氧化钠溶液,分别收集5S后的总光子数;Take 50 μL of 2.5 μM, 10 μM, 40 μM, 100 μM, 250 μM hydrogen peroxide standard solution in two portions, add 50 μL of 1% BSA to the same concentration of one part of hydrogen peroxide standard solution, and add 50 μL of high purity water to the other part. As a control, after incubation at 37 ° C for 0.5 h, 12 h, 24 h, 72 h, 240 h, add 50 μL of 2 M acridine sulfonamide solution, and immediately add 100 μL of 0.25 M sodium hydroxide solution to collect separately. The total number of photons after 5S;
将检测步骤中所测总光子数与建立的线性标准曲线进行对照,通过计算得到加入稳定剂后的过氧化氢浓度C'和未加稳定剂的过氧化氢浓度C,根据公式降解率(H2O2)=(C-C')/C*100%,计算得到过氧化氢的降解率。Comparing the total number of photons measured in the detection step with the established linear standard curve, and calculating the hydrogen peroxide concentration C' after adding the stabilizer and the hydrogen peroxide concentration C without the stabilizer, according to the formula degradation rate (H) 2 O 2 )=(CC')/C*100%, and the degradation rate of hydrogen peroxide was calculated.
所述吖啶磺酰胺的结构式中如下:The structural formula of the acridine sulfonamide is as follows:
Figure PCTCN2017107931-appb-000010
Figure PCTCN2017107931-appb-000010
不同浓度的过氧化氢标准溶液在不同温育时间下的降解率结果如下表:The degradation rates of different concentrations of hydrogen peroxide standard solutions under different incubation times are shown in the following table:
Figure PCTCN2017107931-appb-000011
Figure PCTCN2017107931-appb-000011
由上表可以看出,BSA对过氧化氢的消耗是一个逐渐进行的过程,过氧化氢浓度越高,稳定剂BSA对过氧化氢的降解速率越慢。实际可根据检测结果选择过氧化氢消耗能力合适的稳定剂,比如,当化学发光试剂中过氧化氢含量较高时,可以选择较高浓度过氧化物消耗能力较强的稳定剂,当化学发光试剂中过氧化氢含量较低时,可以选择较低浓度过氧化物消耗能力较弱的稳定剂。As can be seen from the above table, the consumption of hydrogen peroxide by BSA is a gradual process. The higher the concentration of hydrogen peroxide, the slower the degradation rate of hydrogen peroxide by the stabilizer BSA. Actually, a stabilizer suitable for hydrogen peroxide consumption can be selected according to the detection result. For example, when the hydrogen peroxide content in the chemiluminescence reagent is high, a stabilizer having a relatively high concentration of peroxide consumption can be selected, when chemiluminescence is obtained. When the hydrogen peroxide content of the reagent is low, a stabilizer having a relatively low concentration of peroxide consumption can be selected.
本发明采用一类结构的吖啶磺酰胺,通过过氧化氢定量分析方法来测定稳定剂对过氧化氢的消耗能力,由于加稳定剂和不加稳定剂,溶液的pH有所变化,而标准曲线是在不加稳定剂时做出的,采用本发明所用的吖啶磺酰胺适用于测定加稳定剂后的不同pH溶液的过氧化氢含量。The invention adopts a kind of structure of acridine sulfonamide, and the quantitative analysis method of hydrogen peroxide is used to determine the consumption capacity of the stabilizer for hydrogen peroxide. The pH of the solution changes due to the addition of a stabilizer and no stabilizer, and the standard The curve is made without a stabilizer, and the acridine sulfonamide used in the present invention is suitable for determining the hydrogen peroxide content of different pH solutions after the addition of the stabilizer.
以上述依据本发明的理想实施例为启示,通过上述的说明内容,相关工作人员完全可以在不偏离本项发明技术思想的范围内,进行多样的变更以及修改。本项发明的技术性范围并不局限于说明书上的内容,必须要根据权利要求范围来确定其技术性范围。 In view of the above-described embodiments of the present invention, various changes and modifications may be made by those skilled in the art without departing from the scope of the invention. The technical scope of the present invention is not limited to the contents of the specification, and the technical scope thereof must be determined according to the scope of the claims.

Claims (9)

  1. 一种化学发光试剂稳定剂的筛选方法,其特征在于,包括以下步骤,A screening method for a chemiluminescent reagent stabilizer, characterized in that it comprises the following steps,
    选定若干种稳定剂;Selected several stabilizers;
    取体积为V1的一系列的C0-C1浓度范围的过氧化氢标准溶液,分别向其中加入高纯水和体积为V2、浓度为C2的化学发光检测试剂,并立即加入体积为V3、浓度为C3的激发液,分别收集一段时间内的总光子数,通过总光子数与过氧化氢标准溶液的浓度之间的对应关系得到标准曲线;Take a series of C0-C1 concentration range of hydrogen peroxide standard solution with a volume of V1, and add high-purity water and a chemiluminescence detection reagent with a volume of V2 and a concentration of C2, respectively, and immediately add a volume of V3 and a concentration of C3. The excitation liquid collects the total number of photons in a period of time, and obtains a standard curve by the correspondence between the total photon number and the concentration of the hydrogen peroxide standard solution;
    取与建立标准曲线时相同体积的C0-C1浓度范围内某一浓度的过氧化氢标准溶液若干份,份数至少为比稳定剂数量多1份,向其中一份过氧化氢标准溶液中加入与建立标准曲线过程中高纯水体积相同的高纯水,其余份过氧化氢标准溶液中加入与建立标准曲线过程中高纯水体积相同的某一种稳定剂,分别进行温育后,再分别加入体积为V2、浓度为C2的化学发光检测试剂,并立即加入与体积为V3、浓度为C3的激发液,分别收集与建立标准曲线过程中相同时间内的总光子数;将加入某一种稳定剂和高纯水后所测总光子数与建立的标准曲线进行比照,分别得到加入每一种稳定剂后的过氧化氢浓度C'和未加稳定剂的过氧化氢浓度C,根据公式降解率(H2O2)=(C-C')/C*100%,计算得到每一种稳定剂下的过氧化氢的降解率;Take a certain concentration of hydrogen peroxide standard solution in the same volume of C0-C1 concentration range as the standard curve, the number of parts is at least 1 part more than the stabilizer, and add to one of the hydrogen peroxide standard solutions. The high-purity water with the same volume of high-purity water in the process of establishing the standard curve, and the other hydrogen peroxide standard solution are added with the same volume of the high-purity water in the process of establishing the standard curve, respectively, and then separately added to the volume. V2, the chemiluminescence detection reagent with the concentration of C2, and immediately add the excitation liquid with the volume of V3 and the concentration of C3, respectively collect the total photon number in the same time period as the standard curve is established; a certain stabilizer and The total photon number measured after high purity water is compared with the established standard curve, and the hydrogen peroxide concentration C' after adding each stabilizer and the hydrogen peroxide concentration C without stabilizer are obtained respectively, according to the formula degradation rate (H2O2). = (CC') / C * 100%, calculate the degradation rate of hydrogen peroxide under each stabilizer;
    根据每种稳定剂的降解率选择过氧化氢消耗能力合适的化学发光试剂稳定剂。A chemiluminescent reagent stabilizer having a suitable hydrogen peroxide consumption ability is selected according to the degradation rate of each stabilizer.
  2. 根据权利要求1所述的化学发光试剂稳定剂的筛选方法,其特征在于,V2·C2≥1.5(V1·C1),且V2·C2=(2-5)V3·C3。The method for screening a chemiluminescent reagent stabilizer according to claim 1, wherein V2 · C2 ≥ 1.5 (V1 · C1), and V2 · C2 = (2-5) V3 · C3.
  3. 根据权利要求1所述的化学发光试剂稳定剂的筛选方法,其特征在于,所述化学发光检测试剂为吖啶磺酰胺溶液,所述吖啶磺酰胺的结构 式中如下:The method for screening a chemiluminescent reagent stabilizer according to claim 1, wherein the chemiluminescence detecting reagent is an acridinesulfonamide solution, and the structure of the acridinesulfonamide The formula is as follows:
    Figure PCTCN2017107931-appb-100001
    Figure PCTCN2017107931-appb-100001
    其中,R、R'选自烷基及其取代物中的一种,X、X'选自磺酰基、卤素、羧基、N-羟基琥珀酰亚胺中的一种。Wherein R and R' are one selected from the group consisting of an alkyl group and a substituent thereof, and X and X' are one selected from the group consisting of a sulfonyl group, a halogen, a carboxyl group, and an N-hydroxysuccinimide.
  4. 根据权利要求3所述的化学发光试剂稳定剂的筛选方法,其特征在于,所述吖啶磺酰胺为下述结构中的一种:The method for screening a chemiluminescent reagent stabilizer according to claim 3, wherein the acridinesulfonamide is one of the following structures:
    Figure PCTCN2017107931-appb-100002
    Figure PCTCN2017107931-appb-100002
  5. 根据权利要求1所述的化学发光试剂稳定剂的筛选方法,其特征在于,所述稳定剂为BSA、还原性氨基酸和还原性缓冲液中的一种或几种。The method for screening a chemiluminescent reagent stabilizer according to claim 1, wherein the stabilizer is one or more of BSA, a reducing amino acid, and a reducing buffer.
  6. 根据权利要求5所述的化学发光试剂稳定剂的筛选方法,其 特征在于,所述稳定剂为BSA、甘氨酸、谷氨酸、赖氨酸、组氨酸、PB、柠檬酸-Na2HPO4、柠檬酸-TRIS、MES-TRIS、MES-NaOH缓冲液中的一种或几种。The method for screening a chemiluminescent reagent stabilizer according to claim 5, wherein the stabilizer is BSA, glycine, glutamic acid, lysine, histidine, PB, citric acid-Na 2 HPO 4 One or more of citric acid-TRIS, MES-TRIS, MES-NaOH buffer.
  7. 根据权利要求6所述的化学发光试剂稳定剂的筛选方法,其特征在于,所述缓冲液为酸性。The method for screening a chemiluminescent reagent stabilizer according to claim 6, wherein the buffer is acidic.
  8. 根据权利要求1-7任一项所述的化学发光试剂稳定剂的筛选方法,其特征在于,所述温育温度为37℃,时间为0.5h-240h。The method for screening a chemiluminescent reagent stabilizer according to any one of claims 1 to 7, wherein the incubation temperature is 37 ° C and the time is from 0.5 h to 240 h.
  9. 根据权利要求1-8任一项所述的化学发光试剂稳定剂的筛选方法,其特征在于,所述总光子数的收集时间至少为5秒。 The method for screening a chemiluminescent reagent stabilizer according to any one of claims 1 to 8, characterized in that the total photon number collection time is at least 5 seconds.
PCT/CN2017/107931 2017-07-20 2017-10-27 Screening method for a stabilizer for a chemiluminescent reaction WO2019015156A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710594879.0 2017-07-20
CN201710594879.0A CN109283171B (en) 2017-07-20 2017-07-20 Screening method of chemiluminescent reagent stabilizer

Publications (1)

Publication Number Publication Date
WO2019015156A1 true WO2019015156A1 (en) 2019-01-24

Family

ID=65015982

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/107931 WO2019015156A1 (en) 2017-07-20 2017-10-27 Screening method for a stabilizer for a chemiluminescent reaction

Country Status (2)

Country Link
CN (1) CN109283171B (en)
WO (1) WO2019015156A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113419059B (en) * 2021-06-30 2023-09-01 迈克生物股份有限公司 Blocking agent for chemiluminescent immunoassay method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102565405A (en) * 2011-08-24 2012-07-11 苏州长光华医生物试剂有限公司 Method for immunological detection by combining acridinium ester labeling technology with general magnetic particles
CN103163291A (en) * 2013-03-09 2013-06-19 黑龙江八一农垦大学 Kit and operation method thereof
CN103288802A (en) * 2013-06-21 2013-09-11 深圳市美凯特科技有限公司 Preparation method for a series of acridine chemiluminescence agents
US20140335199A1 (en) * 2013-03-05 2014-11-13 Ecolab Usa Inc. Peroxycarboxylic acid compositions suitable for inline optical or conductivity monitoring

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006073424A2 (en) * 2004-04-14 2006-07-13 Giri Brij P New ultra-sensitive chemiluminescent substrates for enzymes and their conjugates
CN1880957A (en) * 2005-06-14 2006-12-20 郑州安图绿科生物工程有限公司 Enzyme-catalyzed chemiluminescence substrate, its synthesis method and enzyme-catalyzed chemiluminescence substrate system
CN103499572B (en) * 2013-10-24 2015-10-28 深圳市鸿美生物医药科技有限公司 A kind of enhanced chemical luminescence reagent
CN105158235B (en) * 2014-06-06 2018-05-08 厦门万泰凯瑞生物技术有限公司 A kind of acridinium ester strengthens luminescent system
CN104849469A (en) * 2015-04-16 2015-08-19 广州市达瑞生物技术股份有限公司 Kit for detecting NGAL content and preparation method thereof
CN106290319B (en) * 2016-08-04 2019-04-05 福建工程学院 A kind of method of silver ion in chemiluminescence detection water sample
CN106771233A (en) * 2016-12-05 2017-05-31 上海良润生物医药科技有限公司 ZnT8A autoantibody detection kits

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102565405A (en) * 2011-08-24 2012-07-11 苏州长光华医生物试剂有限公司 Method for immunological detection by combining acridinium ester labeling technology with general magnetic particles
US20140335199A1 (en) * 2013-03-05 2014-11-13 Ecolab Usa Inc. Peroxycarboxylic acid compositions suitable for inline optical or conductivity monitoring
CN103163291A (en) * 2013-03-09 2013-06-19 黑龙江八一农垦大学 Kit and operation method thereof
CN103288802A (en) * 2013-06-21 2013-09-11 深圳市美凯特科技有限公司 Preparation method for a series of acridine chemiluminescence agents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ZHANG, FAN ET AL.: "Determination of Hydrogen Peroxide with a New Acridinium Ester", CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, vol. 20, no. 3, 31 December 1992 (1992-12-31), pages 342 - 344 *
ZHU, HONGBING ET AL.: "Decomposition Process, Influence Factors and Stabilizer of H202 , Journal of Jiamusi University", NATURAL SCIENCE EDITION, vol. 18, no. 4, 31 December 2000 (2000-12-31), pages 387 - 388 *

Also Published As

Publication number Publication date
CN109283171A (en) 2019-01-29
CN109283171B (en) 2020-04-28

Similar Documents

Publication Publication Date Title
CN105628914B (en) A kind of dilution and preparation method thereof that acridinium ester antigen-antibody conjugate can be made stable
WO2018120620A1 (en) Fluorescence immunochromatographic detection card and preparation method therefor and use thereof
CN101949944B (en) Triiodothyronine quantitative detection kit
CN101949943B (en) Thyrotropic hormone quantitative detection kit
CN102998467B (en) β human chorionic gonadotrophin magnetic microparticle chemiluminescence immune quantitative detection reagent box and preparation method thereof
Lai et al. Enzyme-catalyzed silver deposition on irregular-shaped gold nanoparticles for electrochemical immunoassay of alpha-fetoprotein
CN107831198A (en) A kind of preparation method and application of the optical electro-chemistry cTnI sensor based on multistage micron cube zinc stannate composite
CN107831163A (en) A kind of chemiluminescence detection kit of thyroglobulin and preparation method thereof
CN103472052A (en) Preparation method of multifunctional nanoprobes GOx/AuNPS/DNA, and applications of multifunctional nanoprobes GOx/AuNPS/DNA in kinases detection
CN103048465B (en) IL-6 (Inter Leukin-6) micro-pore plate type chemiluminescent detection kit and manufacturing method thereof
CN111307789B (en) Folic acid detection kit and detection method
CN110455786B (en) Based on CeO2@SnS2Preparation method of luminol-promoted electrochemiluminescence sensor
CN103293299A (en) Method and kit for broadening double-antibody sandwich immunodetection concentration range
US3533749A (en) Method for the determination of total albumin
CN111175491A (en) sBCMA magnetic particle chemiluminescence immunoassay kit and preparation method and application thereof
CN106645738A (en) Anti-cyclic citrullinated peptide antibody chemiluminescence immune detection kit and preparation method thereof
CN102998447A (en) Electrochemical immunosensor for detecting H5N1 subtype avian influenza viruses and manufacturing method of electrochemical immunosensor
WO2019015156A1 (en) Screening method for a stabilizer for a chemiluminescent reaction
CN104076025B (en) A kind of antibacterial peptide electrochemical luminous sensor and preparation method thereof and detection method
Cao et al. An integrated electrochemical immunochromatographic test strip based on the amplification of gold nanoparticles for quantitative detection of alpha-fetoprotein
CN104198706B (en) A kind of preparation method of tumor marker electrochemical immunosensor
CN112305228A (en) Myoglobin direct chemiluminescence detection kit, preparation method and application
Dakubu et al. Time-resolved pulsed fluorescence immunometric assays of carcinoembryonic antigen.
CN108872609A (en) It is a kind of for detecting the time-resolved fluoroimmunoassay kit of canine parvovirus antibody
CN109946461A (en) A kind of B-typeNatriuretic Peptide precursor chemical luminescence detection kit and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17918500

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17918500

Country of ref document: EP

Kind code of ref document: A1